Labcorp announces 2021 fourth quarter and full-year results

BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 10, 2022-- Labcorp  (NYSE: LH), a leading global life sciences company, today announced results for the fourth quarter and year ended Dec. 31, 2021 , full-year 2022 guidance and longer-term outlook.

Labcorp enters comprehensive, long-term laboratory relationship with Ascension

BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 9, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has entered into agreements to create a comprehensive strategic relationship with Ascension, one of the nation’s leading Catholic and non-profit health systems. Through the expansive strategic collaboration, Labcorp will manage Ascension’s hospital-based laboratories in 10 states and purchase select assets of the health system’s outreach laboratory business. This long-term relationship will expand Labcorp’s clinical laboratory services in several states across the country while creating opportunities to enhance care across all clinical areas.

Labcorp opens new laboratory in South Bend, expanding services and access in the Midwest

BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 7, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced the opening of a new diagnostics laboratory in South Bend, Indiana, allowing the company to enhance service levels and offerings to patients and physicians in South Bend and throughout the region.

Labcorp launches Labcorp OnDemand digital health platform

BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 4, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, today announced the launch of Labcorp OnDemand, an easy experience where individuals can purchase Labcorp OnDemand tests online, collect samples in the convenience of their home, or schedule test appointments at one of Labcorp’s 2,000 patient service centers (PSCs), including Labcorp at Walgreens locations. The OnDemand platform includes a suite of the company’s most popular tests, including its wellness, allergy, COVID-19, women’s health and fertility tests, to help individuals manage their health and make more informed decisions. A full list of tests available can be found by visiting www.OnDemand.Labcorp.com.

Labcorp named to Fortune® Magazine’s 2022 ‘World’s Most Admired Companies’ list for the fourth time

BURLINGTON, N.C. --(BUSINESS WIRE)--Feb. 2, 2022-- Labcorp (NYSE: LH), a leading global life sciences company, has been named to FORTUNE® magazine's 2022 list of the World’s Most Admired Companies, marking its fourth appearance on the list. The annual survey, conducted by FORTUNE and Korn Ferry, a global organizational consulting firm, asks top executives, directors and financial analysts to identify the companies with the strongest reputations across various industries.